Helping you make wiser investment decisions

Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class

March 17, 2022 aliu



Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class
aliu
Thu, 03/17/2022 – 06:26



Source link